M&A Deal Summary |
|
|---|---|
| Date | 2019-05-21 |
| Target | KAI Research |
| Sector | Life Science |
| Buyer(s) | Navitas Life Sciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Information Technology |
Navitas Life Sciences is a global technology-enabled clinical research organization (CRO) providing outsourced data science (including biostatistics, statistical programming, and data management), regulatory & safety services (including software and monitoring), and other full-service CRO capabilities to blue-chip large and mid-sized pharmaceutical and government clients. The Company’s functional service expertise optimizes the clinical trial process, drives cost efficiencies for its clients, and ensures adherence to regulatory compliance requirements. Its global operations span the United States, India, Europe, and South America. Navitas Life Sciences is based in Gaithersburg, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2019 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-13 |
DataCeutics
Pottstown, Pennsylvania, United States DataCeutics, Inc. is a specialty Clinical Functional Service Provider (FSP), delivering statistical programming, clinical reporting, and clinical data management. DataCeutics was founded in 1993 and is based in Pottstown, Pennsylvania. |
Buy | - |
